We measured inflammatory responses in PBMCs to TLR stimulation in IC/BPS patients.
Greater responses to TLR-4 stimulation were associated with widespread pain.
Greater responses to TLR-4 stimulation were associated with comorbid conditions.
TLR-4 mediated inflammation may be a therapeutic target in unexplained chronic pain.